• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.针对痘苗病毒西储株的CD8应答中表位层级与免疫流行率之间的解离
J Immunol. 2008 Jun 1;180(11):7193-202. doi: 10.4049/jimmunol.180.11.7193.
2
Immunodomination during peripheral vaccinia virus infection.外周性天花病毒感染期间的免疫优势。
PLoS Pathog. 2013;9(4):e1003329. doi: 10.1371/journal.ppat.1003329. Epub 2013 Apr 25.
3
Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.痘苗病毒特异性CD8(+) T细胞应答靶向一组表位,在人类中不存在强烈的免疫显性等级。
Hum Immunol. 2008 Dec;69(12):815-25. doi: 10.1016/j.humimm.2008.09.009. Epub 2008 Oct 26.
4
Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.痘苗病毒特异性CD4+ T细胞应答所针对的一组抗原,在很大程度上不同于CD8+ T细胞应答所针对的抗原。
J Immunol. 2007 Jun 1;178(11):6814-20. doi: 10.4049/jimmunol.178.11.6814.
5
Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.痘苗病毒感染后 CD8(+) T 细胞免疫优势的改变和近交系及 F(1) 小鼠中的幼稚 repertoire。
J Immunol. 2010 Jan 1;184(1):45-55. doi: 10.4049/jimmunol.0900999. Epub 2009 Nov 30.
6
Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response.分析 A47,一种牛痘病毒的免疫优势蛋白,导致了对总抗病毒 CD8+T 细胞反应的重新评估。
J Virol. 2010 Oct;84(19):10220-9. doi: 10.1128/JVI.01281-10. Epub 2010 Jul 28.
7
Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model.在 HLA-B*07:02 转基因小鼠天花感染模型中针对牛痘病毒的异型免疫。
Sci Rep. 2020 Aug 5;10(1):13167. doi: 10.1038/s41598-020-69897-w.
8
Modified Vaccinia Virus Ankara Can Induce Optimal CD8 T Cell Responses to Directly Primed Antigens Depending on Vaccine Design.改良安卡拉痘苗病毒可根据疫苗设计诱导直接刺激抗原的最佳 CD8 T 细胞应答。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.01154-19. Print 2019 Nov 1.
9
Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus.全身扩散程度决定了实验室毒株、天花疫苗和痘苗病毒人畜共患病分离株的CD8 + T细胞免疫显性。
J Immunol. 2015 Sep 1;195(5):2263-72. doi: 10.4049/jimmunol.1402508. Epub 2015 Jul 20.
10
Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides.痘苗病毒CD8 + T细胞优势等级不能通过预先用单个肽免疫来改变。
J Virol. 2009 Sep;83(17):9008-12. doi: 10.1128/JVI.00410-09. Epub 2009 Jun 17.

引用本文的文献

1
An Attenuated and Highly Immunogenic Variant of the Vaccinia Virus.痘苗病毒的一种减毒且高免疫原性变体。
Acta Naturae. 2024 Apr-Jun;16(2):82-89. doi: 10.32607/actanaturae.27384.
2
Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus.ati基因缺失对痘苗病毒致病性和免疫原性的影响。
Acta Naturae. 2023 Jul-Sep;15(3):82-90. doi: 10.32607/actanaturae.17872.
3
Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing.人类和小鼠中相关的CD4和CD8 T细胞免疫显性:对临床前测试的意义。
Cell Mol Immunol. 2023 Nov;20(11):1328-1338. doi: 10.1038/s41423-023-01083-0. Epub 2023 Sep 19.
4
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.新设计的痘病毒启动子可提高MVA-NP候选疫苗对小鼠致命性流感病毒感染的免疫原性和效力。
Pathogens. 2023 Jun 23;12(7):867. doi: 10.3390/pathogens12070867.
5
Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.定义抗原靶点,以解析人类中天花病毒和猴痘病毒特异性 T 细胞反应。
Cell Host Microbe. 2022 Dec 14;30(12):1662-1670.e4. doi: 10.1016/j.chom.2022.11.003. Epub 2022 Dec 3.
6
Enhancing the Immunogenicity of Vaccinia Virus.增强天花病毒的免疫原性。
Viruses. 2022 Jun 30;14(7):1453. doi: 10.3390/v14071453.
7
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.对 HIV-1 CRF01_AE 亚型感染早期 HLA-B*13 限制性 T 细胞反应的免疫逃逸进行的纵向分析及其对疫苗设计的意义。
BMC Immunol. 2022 Apr 2;23(1):15. doi: 10.1186/s12865-022-00491-7.
8
A Framework to Identify Antigen-Expanded T Cell Receptor Clusters Within Complex Repertoires.一种在复杂受体库中识别抗原扩增的 T 细胞受体簇的框架。
Front Immunol. 2021 Nov 30;12:735584. doi: 10.3389/fimmu.2021.735584. eCollection 2021.
9
Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus.BALB/c 小鼠对牛痘病毒 LIVP 感染的适应性免疫反应及对致死性重新感染牛痘病毒的保护作用。
Viruses. 2021 Aug 17;13(8):1631. doi: 10.3390/v13081631.
10
SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.严重急性呼吸综合征冠状病毒2型人类T细胞表位:针对2019冠状病毒病的适应性免疫反应
Cell Host Microbe. 2021 Jul 14;29(7):1076-1092. doi: 10.1016/j.chom.2021.05.010. Epub 2021 May 21.

本文引用的文献

1
A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.对痘苗病毒感染后所识别的T细胞特异性库影响因素的定量分析。
J Immunol. 2007 Jun 15;178(12):7890-901. doi: 10.4049/jimmunol.178.12.7890.
2
Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.丙型肝炎病毒NS3和核心蛋白混杂CD4 + T细胞表位的天然供体中T细胞启动的差异能力。
Eur J Immunol. 2007 Jun;37(6):1513-23. doi: 10.1002/eji.200636783.
3
Human T-cell responses to vaccinia virus envelope proteins.人类T细胞对痘苗病毒包膜蛋白的反应。
J Virol. 2006 Oct;80(20):10010-20. doi: 10.1128/JVI.00601-06.
4
Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family.MAGE-A基因家族编码的HLA-DP4结合T细胞表位的选择性鉴定。
Cancer Immunol Immunother. 2007 Jun;56(6):807-18. doi: 10.1007/s00262-006-0230-y. Epub 2006 Sep 20.
5
Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.痘苗病毒CD8 + T细胞表位的鉴定,这些表位在痘苗病毒和天花病毒中保守,受常见的MHC I类分子HLA - A2或HLA - B7限制。
Hum Immunol. 2006 Jul;67(7):512-20. doi: 10.1016/j.humimm.2005.12.004. Epub 2006 May 4.
6
HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses.HLA - A2限制的人类CD8(+)细胞毒性T淋巴细胞对痘苗病毒中一种在正痘病毒间保守的新型表位的反应。
J Infect Dis. 2006 Jul 15;194(2):168-75. doi: 10.1086/505224. Epub 2006 Jun 12.
7
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice.痘病毒CD8 + T细胞决定簇及BALB/c小鼠中的交叉反应性
J Virol. 2006 Jul;80(13):6318-23. doi: 10.1128/JVI.00427-06.
8
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.一种共识表位预测方法确定了小鼠T(CD8 +)细胞对痘苗病毒反应的广度。
Nat Biotechnol. 2006 Jul;24(7):817-9. doi: 10.1038/nbt1215. Epub 2006 Jun 11.
9
Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule.在HIV基因组中扫描受限于HLA-DP4(最常见的HLA II类分子)的CD4+ T细胞表位。
J Immunol. 2006 May 1;176(9):5401-8. doi: 10.4049/jimmunol.176.9.5401.
10
Diversity in the acute CD8 T cell response to vaccinia virus in humans.人类对痘苗病毒急性CD8 T细胞反应的多样性。
J Immunol. 2005 Dec 1;175(11):7550-9. doi: 10.4049/jimmunol.175.11.7550.

针对痘苗病毒西储株的CD8应答中表位层级与免疫流行率之间的解离

Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.

作者信息

Oseroff Carla, Peters Bjoern, Pasquetto Valerie, Moutaftsi Magdalini, Sidney John, Panchanathan Vijay, Tscharke David C, Maillere Bernard, Grey Howard, Sette Alessandro

机构信息

Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.

出版信息

J Immunol. 2008 Jun 1;180(11):7193-202. doi: 10.4049/jimmunol.180.11.7193.

DOI:10.4049/jimmunol.180.11.7193
PMID:18490718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2533852/
Abstract

Understanding immunity to vaccinia virus (VACV) is important for the development of safer vaccines for smallpox- and poxvirus-vectored recombinant vaccines. VACV is also emerging as an outstanding model for studying CD8(+) T cell immunodominance because of the large number of CD8(+) T cell epitopes known for this virus in both mice and humans. In this study, we characterize the CD8(+) T cell response in vaccinated BALB/c mice by a genome-wide mapping approach. Responses to each of 54 newly identified H-2(d)-restricted T cell epitopes could be detected after i.p. and dermal vaccination routes. Analysis of these new epitopes in the context of those already known for VACV in mice and humans revealed two important findings. First, CD8(+) T cell epitopes are not randomly distributed across the VACV proteome, with some proteins being poorly or nonimmunogenic, while others are immunoprevalent, being frequently recognized across diverse MHC haplotypes. Second, some proteins constituted the major targets of the immune response by a specific haplotype as they recruited the majority of the specific CD8(+) T cells but these proteins did not correspond to the immunoprevalent Ags. Thus, we found a dissociation between immunoprevalence and immunodominance, implying that different sets of rules govern these two phenomena. Together, these findings have clear implications for the design of CD8(+) T cell subunit vaccines and in particular raise the exciting prospect of being able to choose subunits without reference to MHC restriction.

摘要

了解对痘苗病毒(VACV)的免疫对于开发更安全的天花疫苗和痘病毒载体重组疫苗至关重要。由于在小鼠和人类中已知该病毒有大量的CD8(+) T细胞表位,VACV也正在成为研究CD8(+) T细胞免疫显性的杰出模型。在本研究中,我们通过全基因组定位方法对接种疫苗的BALB/c小鼠中的CD8(+) T细胞反应进行了表征。经腹腔注射和皮肤接种途径后,可检测到对54个新鉴定的H-2(d)限制性T细胞表位中每一个的反应。在小鼠和人类中已针对VACV所知的那些表位的背景下对这些新表位进行分析,揭示了两个重要发现。首先,CD8(+) T细胞表位并非随机分布在VACV蛋白质组中,一些蛋白质免疫原性差或无免疫原性,而其他蛋白质则具有免疫普遍性,在不同的MHC单倍型中经常被识别。其次,一些蛋白质作为特定单倍型免疫反应的主要靶点,因为它们募集了大多数特定的CD8(+) T细胞,但这些蛋白质并不对应于免疫普遍的抗原。因此,我们发现免疫普遍性和免疫显性之间存在分离,这意味着不同的规则集支配这两种现象。这些发现共同对CD8(+) T细胞亚单位疫苗的设计具有明确的意义,特别是提出了能够在不参考MHC限制的情况下选择亚单位的令人兴奋的前景。